Literature DB >> 18178963

Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.

Shao H Yang1, Xin Qiao, Emily Farber, Sandy Y Chang, Loren G Fong, Stephen G Young.   

Abstract

Hutchinson-Gilford progeria syndrome is caused by the synthesis of a mutant form of prelamin A, which is generally called progerin. Progerin is targeted to the nuclear rim, where it interferes with the integrity of the nuclear lamina, causes misshapen cell nuclei, and leads to multiple aging-like disease phenotypes. We created a gene-targeted allele yielding exclusively progerin (Lmna HG) and found that heterozygous mice (Lmna HG/+) exhibit many phenotypes of progeria. In this study, we tested the hypothesis that the phenotypes elicited by the Lmna HG allele might be modulated by compositional changes in the nuclear lamina. To explore this hypothesis, we bred mice harboring one Lmna HG allele and one Lmna LCO allele (a mutant allele that produces lamin C but no lamin A). We then compared the phenotypes of Lmna HG/LCO mice (which produce progerin and lamin C) with littermate Lmna HG/+ mice (which produce lamin A, lamin C, and progerin). Lmna HG/LCO mice exhibited improved HG/LCO fibroblasts had fewer misshapen nuclei than Lmna HG/+ fibroblasts (p < 0.0001). A likely explanation for these differences was uncovered; the amount of progerin in Lmna HG/LCO fibroblasts and tissues was lower than in Lmna HG/+ fibroblasts and tissues. These studies suggest that compositional changes in the nuclear lamina can influence both the steady-state levels of progerin and the severity of progeria-like disease phenotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178963     DOI: 10.1074/jbc.M708138200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Nuclear mechanics in disease.

Authors:  Monika Zwerger; Chin Yee Ho; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

Review 2.  Nuclear shape, mechanics, and mechanotransduction.

Authors:  Kris Noel Dahl; Alexandre J S Ribeiro; Jan Lammerding
Journal:  Circ Res       Date:  2008-06-06       Impact factor: 17.367

Review 3.  Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin.

Authors:  Thomas Dechat; Katrin Pfleghaar; Kaushik Sengupta; Takeshi Shimi; Dale K Shumaker; Liliana Solimando; Robert D Goldman
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

4.  Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.

Authors:  Catherine Coffinier; Hea-Jin Jung; Ziwei Li; Chika Nobumori; Ui Jeong Yun; Emily A Farber; Brandon S Davies; Michael M Weinstein; Shao H Yang; Jan Lammerding; Javad N Farahani; Laurent A Bentolila; Loren G Fong; Stephen G Young
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

Review 5.  Altered nuclear functions in progeroid syndromes: a paradigm for aging research.

Authors:  Baomin Li; Sonali Jog; Jose Candelario; Sita Reddy; Lucio Comai
Journal:  ScientificWorldJournal       Date:  2009-12-16

6.  Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.

Authors:  Gabriela Viteri; Youn Wook Chung; Earl R Stadtman
Journal:  Mech Ageing Dev       Date:  2009-12-01       Impact factor: 5.432

7.  Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.

Authors:  Shao H Yang; Douglas A Andres; H Peter Spielmann; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 8.  The posttranslational processing of prelamin A and disease.

Authors:  Brandon S J Davies; Loren G Fong; Shao H Yang; Catherine Coffinier; Stephen G Young
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

9.  Modulation of LMNA splicing as a strategy to treat prelamin A diseases.

Authors:  John M Lee; Chika Nobumori; Yiping Tu; Catherine Choi; Shao H Yang; Hea-Jin Jung; Timothy A Vickers; Frank Rigo; C Frank Bennett; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

10.  Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.

Authors:  Shao H Yang; Sandy Y Chang; Douglas A Andres; H Peter Spielmann; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2009-10-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.